Join
Live feed
·
INSIDERFilingvia Quantisnow
Adaptimmune Therapeutics plc logo

Rawcliffe Adrian sold $27,594 worth of American Depositary Shares representing Ordinary Shares (39,384 units at $0.70), increasing direct ownership by 92% to 44,848 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ADAP· Adaptimmune Therapeutics plc
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ADAP (Adaptimmune Therapeutics plc) and more on Quantisnow.

Rawcliffe Adrian sold $27,594 worth of American Depositary Shares representing Ordinary Shares (39,384 units at $0.70), increasing direct ownership by 92% to 44,848 units (SEC Form 4) | Quantisnow